22 April 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Department
Michał Machowski
1ABCDEF, Aisha Ou-Pokrzewińska1BCDEF, Katarzyna Perzanowska-Brzeszkiewicz 1BCDEF, Magdalena Gałecka-Nowak 1BDE, Szymon Pacho1BDE, Mateusz Jermakow 1BCDE*, Agnieszka Wójcik1BDE, Milena Zoruk1BDE, Andrzej Pruszczyk 1BDE, Karol Deutsch1BDE, Marek Roik 1BDE, Andrzej Łabyk 1BDE, Piotr Palczewski 2ABDEF, Piotr Pruszczyk 1ABCDEF
DOI: 10.12659/MSM.942612
Med Sci Monit 2024; 30:e942612
Table 3 Cardiac biomarkers and echocardiographic data according to the diagnosed acute cardiovascular diseases.
| Parameter [unit] | ACS (n=40) | PE (n=42) | AMyo (n=19) | COVID-19 (n=148) | P-value | Post-hoc |
|---|---|---|---|---|---|---|
| High-sensitive troponin T [ng/ml] | 153.5 (59.0; 788.2) | 26.0 (13.2; 71.5) | 75.5 (37.0; 792.0) | 22.5 (16.0; 43.2) | <0.001 | ACS >PE, ACS>COVID-19, Myo>PE, Myo>COVID-19 |
| NT-proBN [pg/ml] | 4200 (1271; 10 170) | 962 (318; 2 246) | 9083 (909; 24 541) | 996 (33; 4114) | 0.002 | ACS>PE, ACS>COVID-19, Myo>PE, Myo>COVID-19 |
| D-dimer [ng/ml] | 1 494 (733; 2 812) | 12 675 (2 119; 25 459) | 1317 (825; 1909) | 959.00 (578; 1 509) | <0.001 | PE>COVID-19, PE>Myo |
| Right ventricular dysfunction, n (%) | 0 (0.0) | 20 (47.6) | 0 (0.0) | 3 (2.0) | <0.001 | |
| Left ventricle ejection fraction [%] | 44.9 (11.6) | 57.6 (5.8) | 25.7 (9.3) | 54.9 (9.7) | <0.001 | ACS |
| ACS – acute coronary syndrome; AMyo – acute myocarditis; APE – acute pulmonary embolism; CAD – coronary artery disease; CHF – congestive heart failure; CRP – C-reactive protein; MEWS – Modified Early Warning Score. | ||||||